跳至主要内容
临床试验/EUCTR2013-005001-31-ES
EUCTR2013-005001-31-ES进行中(未招募)1 期

Randomized clinical trial on the prevention of radiographic progression with zoledronic acid in patients with early rheumatoid arthritis and low disease activity - Prevention of radiographic progression in rheumatoid arthritis with zoledronic acid

Dra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell)0 个研究点开始时间: 2014年2月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age ? 18 years
  • 2. Patients with RA of less than 2 years of evolution
  • 3. DMARD therapy (methotrexate alone or methotrexate, leflunomide or methotrexate within COBRA strategy) on stable dose for at least 6 weeks prior to study entry
  • 4. Patients not treated with glucocorticoids or under stable dose of prednisone up to 5 mg / day or equivalent dose of another glucocorticoid
  • 5. Low disease activity (DAS28 <3.2)
  • 6. Im case of premenopausal women, commitment to make contraceptive treatment up to 3 years after the last dose of zoledronic acid
  • 7. Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 62
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 32

排除标准

  • 1. Previous or current treatment with biological drugs used for the treatment of RA (infliximab, adalimumab, etanercept, certolizumab, golimumab, rituximab, abatacept, tocilizumab)
  • 2. Pretreatment with:
  • a. Bisphosphonates in the 5 years prior to the onset of RA
  • b. Calcitonin, raloxifene, bazedoxifene, strontium ranelate, teriparatide and denosumab in the year before the onset of RA
  • 3. Contraindication to treatment with zoledronic acid:
  • a. Hypersensitivity to bisphosphonates
  • b. Hypocalcemia
  • c. Glomerular filtration rate <35 mL / min
  • d. Pregnant (negative pregnancy test) and lactating women
  • e. Poor oral hygiene
  • f. Pending invasive dental procedure
  • 4. Serum levels of calcidiol lower than 25 nmol/L (10 ng/mL).
  • 5. Simultaneous participation in another clinical trial

研究者

发起方
Dra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell)

相似试验

Study on the ability of zoledronic acid to prevent... | 临床试验